ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in VivoNewsfile Corp • 01/14/25
Watch These Moderna Price Levels as Stock Plummets After Slashing 2025 Revenue OutlookInvestopedia • 01/14/25
S&P 500 Gains and Losses Today: Moderna Plunges After Big Cut to Sales ForecastInvestopedia • 01/13/25
S&P 500, Nasdaq slip as key tech stocks fall; US Steel shares jump, Moderna stock tanksInvezz • 01/13/25
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 GuidanceInvestors Business Daily • 01/13/25
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceAccesswire • 01/13/25